[March 11, 2014] |
 |
Research and Markets: Concise Analysis of the International Cancer/Tumor Profiling Market - Forecasts to 2018
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/rx3gd8/cancertumor)
has announced the addition of the "Concise
Analysis of the International Cancer/Tumor Profiling Market - Forecasts
to 2018" report to their offering.
The global tumor profiling market is anticipated to reach $35.03 billion
by 2018 growing at a CAGR of 18.50%. The market is divided by geography
(North America, Europe, Asia-Pacific, and Rest of the World),
applications (Personalized Medicine, Diagnostics, Biomarker Discovery,
Prognosis (News - Alert), and Research Applications), technologies (Next-Generation
Sequencing, Quantitative PCR, Immunohistochemistry, FISH/CISH, and
Microarray) and segments (Genomics, Proteomics, Metabolomics, and
Epigenetics). Further, each application, technology, and segment type is
broken down by geography, with an exhaustive revenue analysis for the
entire forecast period. Of the above mentioned applications,
Personalized Medicine is the largest revenue sector and will be the
fastest-growing segment.
The cancer profiling market is driven mainly by the rising number of
cancer cases. Technological advancements to identify the exact cause of
the condition are considered as the second major driver. Additionally,
demand for safer and cost-effective treatment further drives the market.
The rapid growth of the tumor profiling market is attributed to its
promising application in personalized cancer therapy; and its extension
in early diagnosis, disease prognosis, and research applications will
further enhance its market growth. The current approach of cancer
profiling in targeted therapy and personalized medicine for cancer has
the potential to address the current demands and fill the gaps in the
healthcare industry.
Key Topics Covered:
1 Introduction
2 Executive Summary
3 Tumor Profiling Technology Landscape
4 Tumor Profiling Research Portfolio
5 Value Chain Analysis
6 Market Landscape Analysis
7 Technology Adoption And Development Potential, By Geography
8 Technology Investment Analysis
9 Competitive Landscape Analysis
10 Patent Analysis
11 Analyst Insights And Recommendations
12 Company Profiles
Companies Mentioned:
-
Agendia Nv
-
Biotheranostics
-
Boreal Genomics, Inc
-
Caris Life Sciences
-
Genomic Health, Inc
-
Illumina, Inc
-
Life Technologies Corporation
-
Nanostring Technologies
-
Neogenomics Laboratories
-
Oncopath Laboratory
-
Oxford Gene Technology Ltd
-
Precision Therapeutics, Inc
-
Proteome Sciences Plc
-
Rational Therapeutics
-
Ribomed Biotechnologies
For more information visit http://www.researchandmarkets.com/research/rx3gd8/cancertumor

[ Back To TMCnet.com's Homepage ]
|